78 articles for B Wu
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
37
Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitors.

Amgen
18
Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors.

Amgen
26
Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors.

Amgen
31
The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors.

Amgen
5
Synthesis and Structure-Activity Relationship Study of 5a-Carbasugar Analogues of SL0101.

Northeastern University
1
Targeting (cellular) lysosomal acid ceramidase by B13: design, synthesis and evaluation of novel DMG-B13 ester prodrugs.

Medical University of South Carolina
8
Improving the affinity of SL0101 for RSK using structure-based design.

Vanderbilt University
20
Selective class I phosphoinositide 3-kinase inhibitors: optimization of a series of pyridyltriazines leading to the identification of a clinical candidate, AMG 511.

Amgen
4
BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.

Sanford-Burnham Medical Research Institute
43
Semi-synthetic aristolactams--inhibitors of CDK2 enzyme.

Schering-Plough Research Institute
19
C-5 substituted heteroaryl-3-pyridinecarbonitriles as PKCtheta inhibitors: part II.

Wyeth Research
21
Synthesis and PKCtheta inhibitory activity of a series of 4-(indol-5-ylamino)thieno[2,3-b]pyridine-5-carbonitriles.

Wyeth Research
2
Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.

Genomics Institute of The Novartis Research Foundation
20
Discovery of potent and highly selective thienopyridine Janus kinase 2 inhibitors.

Amgen
37
SAR by interligand nuclear overhauser effects (ILOEs) based discovery of acylsulfonamide compounds active against Bcl-x(L) and Mcl-1.

Sanford-Burnham Medical Research Institute
12
Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.

Sanford-Burnham Medical Research Institute
23
Discovery of pyridazinopyridinones as potent and selective p38 mitogen-activated protein kinase inhibitors.

Amgen
19
Optimization of 7-alkene-3-quinolinecarbonitriles as Src kinase inhibitors.

Wyeth Research
31
Optimization of 5-vinylaryl-3-pyridinecarbonitriles as PKCtheta inhibitors.

Wyeth Research
2
New potential antitumor compounds from the plant Aristolochia manshuriensis as inhibitors of the CDK2 enzyme.

Schering-Plough Research Institute
26
First generation 5-vinyl-3-pyridinecarbonitrile PKCtheta inhibitors.

Wyeth Research
21
C-5 Substituted heteroaryl 3-pyridinecarbonitriles as PKCtheta inhibitors: Part I.

Wyeth Research
15
4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.

Wyeth Research
28
Optimization of 5-phenyl-3-pyridinecarbonitriles as PKCtheta inhibitors.

Wyeth Research
12
Second generation 4-(4-methyl-1H-indol-5-ylamino)-2-phenylthieno[2,3-b]pyridine-5-carbonitrile PKCtheta inhibitors.

Wyeth Research
3
Complex sesquiterpenoids with tyrosinase inhibitory activity from the leaves of Chloranthus tianmushanensis.

Zhejiang University
10
Novel Spiro-Barbiturates Can Reverse the Action of General Anesthetics on the GABAAR.

University of Illinois Chicago
88
Nuclear magnetic resonance fragment-based identification of novel FKBP12 inhibitors.

University of California San Diego
27
Design, synthesis and biological evaluation of 4-(indolin-1-yl)-6-substituted-pyrido[3,2-d]pyrimidine derivatives as Mnk1/2 inhibitors.

Shenyang Pharmaceutical University
15
Exploring gabosine and chlorogentisyl alcohol derivatives from a marine-derived fungus as EcGUS inhibitors with informatic assisted approaches.

Zhejiang University
16
7-(aryl/heteroaryl-2-ylethynyl)-4-phenylamino-3-quinolinecarbonitriles as new Src kinase inhibitors: addition of water solubilizing groups.

Wyeth Research
10
Synthetic methodology-enabled discovery of a tunable indole template for COX-1 inhibition and anti-cancer activity.

Georgia Institute of Technology
20
Design, synthesis and activity evaluation of isopropylsulfonyl-substituted 2,4- diarylaminopyrimidine derivatives as FAK inhibitors for the potential treatment of pancreatic cancer.

Dalian Medical University
52
Synthesis and Pharmacological Evaluation of Tetrahydro-γ-carboline Derivatives as Potent Anti-inflammatory Agents Targeting Cyclic GMP-AMP Synthase.

Shanghai Institute of Materia Medica (Simm)
15
Synthesis and evaluation of 4-anilino-6,7-dialkoxy-3-quinolinecarbonitriles as inhibitors of kinases of the Ras-MAPK signaling cascade.

Wyeth Research
18
Design and synthesis of novel selective anaplastic lymphoma kinase inhibitors.

Genomics Institute of The Novartis Research Foundation
8
4-Anilino-3-cyanobenzo[g]quinolines as kinase inhibitors.

Wyeth-Ayerst Research
20
Design, synthesis and biological evaluation of triaryl compounds as novel 20S proteasome inhibitors.

Peking Union Medical College
6
Pyrimethamine conjugated histone deacetylase inhibitors: Design, synthesis and evidence for triple negative breast cancer selective cytotoxicity.

Georgia Institute of Technology
26
MEK (MAPKK) inhibitors. Part 2: structure-activity relationships of 4-anilino-3-cyano-6,7-dialkoxyquinolines.

Wyeth-Ayerst Research
15
Synthesis and structure-activity relationships of 3-cyano-4-(phenoxyanilino)quinolines as MEK (MAPKK) inhibitors.

Wyeth-Ayerst Research
26
Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors.

Amgen
34
3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H.

University of Minnesota
66
3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations.

University of Minnesota
3
Cyclic tripeptide-based potent human SIRT7 inhibitors.

Jiangsu University
27
Discovery of ( R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4- b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3 H)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological Malignancies.

TBA
32
Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on an

Chinese Academy of Sciences
2
Polygala tenuifolia-Acori tatarinowii herbal pair as an inspiration for substituted cinnamic α-asaronol esters: Design, synthesis, anticonvulsant activity, and inhibition of lactate dehydrogenase study.

Northwest University
38
Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones.

Birla Institute of Technology
14
7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as dual inhibitors of Src and Abl kinases.

Wyeth Research
35
Structure-Based Design of 1-Heteroaryl-1,3-propanediamine Derivatives as a Novel Series of CC-Chemokine Receptor 5 Antagonists.

University of Chinese Academy of Sciences
7
Phosphamide-containing diphenylpyrimidine analogues (PA-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with enhanced activity against pancreatic cancer cell lines.

Dalian Medical University
41
Discovery of Tarantula Venom-Derived Na

Amgen
21
Click-Chemistry-Mediated Synthesis of Selective Melanocortin Receptor 4 Agonists.

University of Copenhagen
3
Uses of a lysyl oxidase-like 2 inhibitor

Pharmakea
124
Pharmaceutical compounds

Pfizer
9
Therapeutic pyrazolyl thienopyridines

Fbm Therapeutics
411
1,3-thiazol-2-yl substituted benzamides

Bayer
36
Aryl amide-based kinase inhibitors

Bristol Myers Squibb
825
Metallo-beta-lactamase inhibitors

Merck Sharp & Dohme
34
Fused bicyclic 1,2,4-triazine compounds as TAM inhibitors

Incyte
29
N-cyanomethylamides as inhibitors of janus kinase

Cadila Healthcare
5
Metalloenzyme inhibitor compounds

Viamet Pharmaceuticals
245
6-substituted phenoxychroman carboxylic acid derivatives

Array Biopharma
110
Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors

H. Lundbeck
12
Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in Metabolism.

Pfizer
38
Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors

Aeterna Zentaris
145
Fused ring compound and use thereof

Takeda Pharmaceutical
2
Design and synthesis of a tetrahydroisoquinoline-based hydroxamate derivative (ZYJ-34v), an oral active histone deacetylase inhibitor with potent antitumor activity.

Shandong University
24
Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogs.

Research Triangle Institute
26
Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.

Alcon Laboratories
20
Cyclic sulfamide HIV-1 protease inhibitors, with sidechains spanning from P2/P2' to P1/P1'.

Uppsala University
35
SYNTHESIS AND PHARMACOKINETICS OF POTENT CARBAMATE HIV-1 PROTEASE INHIBITORS CONTAINING NOVEL HIGH AFFINITY HYDROXYETHYLAMINE ISOSTERES

Eli Lilly
16
Cycloalkylpiperazines as HIV-1 Protease Inhibitors: Enhanced Oral Absorption

Merck Research Laboratories
5
Thermodynamic analysis of the binding of the polyglutamate chain of 5-formyltetrahydropteroylpolyglutamates to serine hydroxymethyltransferase.

Virginia Commonwealth University
4
DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5'-methyl group of the noviose.

Umr Cnrs 6032